Helena Smolek

Pharma shares in Asia and Europe have dropped this morning significantly, especially Novo Nordisk, who derives a large share of profit from the US. It could be one of the hardest hit. Hence, its share price is among the biggest losers in European morning trading.

Pharma shares in Asia and Europe have dropped this morning significantly, especially Novo Nordisk, who derives a large share of profit from the US. It could be one of the hardest hit. Hence, its share price is among the biggest losers in European morning trading.

Overall, there's this tone or this overall view of drug makers not being in favor of that policy since it would mean a major profit fall for them. However, drug makers as well as analysts share the view that the significant price gap between U.S. and other countries is no longer sustainable and has to change.

Overall, there's this tone or this overall view of drug makers not being in favor of that policy since it would mean a major profit fall for them. However, drug makers as well as analysts share the view that the significant price gap between U.S. and other countries is no longer sustainable and has to change.

Thank you.

Thank you.